If there has been no surgical operation, it is possible to attempt firstly to treat the neoplasia through urethral catheters which allow the spreading of the saline solutions inside the prostatic lobes through the ducts. To this it is possible to associate periglandular infiltrations implementable transrectally by utilising very long needles of the type used for amniocentesis. Where it is not possible to treat the mass adequately or in the presence of post-surgical relapse, the administration of sodium bicarbonate to be repeated in cycles of 6-7-8 days per month directly in the pudendal artery generally turns out to be extremely effective.
In the presence of a concomitant invasion of the pelvic cavity, it is possible to adopt the same therapeutic scheme used for peritoneal carcinosis, that is, by using a small catheter to position inside the abdomen and close to the mass.
Possible bone metastasis, instead, requires a completely different therapeutic approach, which depends on both the number and location of the lesions.
If the lesions are not numerous, it is appropriate to program for each one a cycle of targeted radiotherapy, supported by administrations of 500 cc sodium bicarbonate phleboclyses, to perform after each session with the purpose of preventing a further germination and spreading of fungin cells.
Each physical treatment that destroys neoplastic matter, in fact, implies the simultaneous destruction of a quota of the tissues of the host. It is this cellular death that works as both bait and lifesaver for the fungin cells which manage to survive by nourishing themselves with the decomposing tissues. Radiotherapy, laser therapy or thermo-ablation generally fail for this reason, as they leave at the periphery of the treated area those cellular units that are able to vigorously resume the proliferation once the treatment is over. Of this I am convinced because I have studied in depth the behaviour of the fungin colonies, especially during the first years of application of my method of therapy. In the presence of epithelial tumours, I even tried to burn them with instruments that were red hot, and well beyond their dimensions. But it was useless. After just 10-20 minutes, I was observing fungin cells at the periphery of the burn that were more vital than ever.
There is no doubt that primary or secondary pleuric neoplasias are amongst the easiest to treat with the therapy method I propose, as I have observed in almost all the cases the complete regression of the disease unless in the presence of a previous pleurodesys intervention.
Method: After the positioning of an endopleuric catheter with the ecographic guide and after the drainage of the existing liquid, administer 150-200 ccs in the cavity for three consecutive days, then on alternative days for 12 days. From the 15th to the 30th day, administer 100-150 ccs and drain after one hour – this to be performed one day on and two off.
Normally, after the fourth-fifth day, the hemothorax – if it was present – disappears, and after 10-15 days (except in some rare cases) it is no longer necessary to aspirate liquids, as the pleura has gone back to normal. Much attention is to be paid to the medication of the gauzes and of the catheter, as both can become very dangerous sources of infection and of pleuric empyema – an episode that can occur also in the case when too elevated dosages of salts are administered.
There is a great variety of tumours that develop in the upper and lower limbs. The tumours are both primary and metastatic. Osteosarcoma, Ewing’s sarcomas, condrosarcomas, and others mainly belong to a juvenile pathology while the metastatic types concern more adult pathology.
The attempt to destroy them consists in sodium bicarbonate solution at five per cent in doses that are proportional to the weight of the patient.
This is achieved through the application of catheters in the arteries in the afferent arteries to each limb. All the masses downstream of the application point generally regress almost completely, even though in some cases the effects of the therapy become visible only three to four months later when, that is, the tissue re-absorption and reshaping phenomena are almost completed.
The only real problem with this therapy is that the arteries of a young patient are of small cross-section, and that means that for each administration the solicitations and the stretching of the nerva vasorum produce a steady, painful symptomatology. The symptoms, however, are temporary, and concern only the period of administration. Nevertheless this sometimes forces the suspension of the treatment for one or two days.
In the case of bone metastasis, it is possible to obtain an almost complete remission of the painful symptoms by performing direct percutaneal infiltrations on each lesion. This can be done by leaving a cannula needle in contact with the bone.
